

11.2.1.

2 (weak)

C (low to
very low)

In patients who are symptomatic following thermal or nonthermal ablation, we
recommend early DUS to exclude ARTE or DVT.

11.2. Pharmacological thromboprophylaxis

For high-risk patients undergoing endovenous ablation we suggest pharmacological
thromboprophylaxis.

Consensus statement
11.2.2.

For patients undergoing end